Q1 2021 13F Holders as of 31 Mar 2021
-
Type / Class
-
Equity / Common Shares, no par value per share
-
Shares outstanding
-
47.6M
-
Number of holders
-
68
-
Total 13F shares, excl. options
-
30.8M
-
Shares change
-
+7.72M
-
Total reported value, excl. options
-
$896M
-
Value change
-
+$247M
-
Number of buys
-
55
-
Number of sells
-
-15
-
Price
-
$29.05
Significant Holders of ESSA Pharma Inc. - Common Shares, no par value per share (EPIX) as of Q1 2021
74 filings reported holding EPIX - ESSA Pharma Inc. - Common Shares, no par value per share as of Q1 2021.
ESSA Pharma Inc. - Common Shares, no par value per share (EPIX) has 68 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 30.8M shares
of 47.6M outstanding shares and own 64.78% of the company stock.
Largest 10 shareholders include Blackstone Group Inc. (3.57M shares), BVF INC/IL (2.91M shares), Avidity Partners Management LP (2.84M shares), EVENTIDE ASSET MANAGEMENT, LLC (2.41M shares), Soleus Capital Management, L.P. (2.07M shares), Vivo Capital, LLC (2.07M shares), Bellevue Group AG (1.83M shares), JANUS HENDERSON GROUP PLC (1.52M shares), ADAGE CAPITAL PARTNERS GP, L.L.C. (1.35M shares), and FMR LLC (797K shares).
This table shows the top 68 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.